Probiotics are widely involved in BA anabolism pathways, including that of CDCA, DCA, and LCA, and can regulate FXR signaling and the composition of the intestinal microbiota [117]; therefore, they may be used as potential adjuvant treatment for cholestasis. This evidence concerns the gene NR1H4 and cholestasis.